Parabilis Medicines, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: PBLS
Parabilis Medicines, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker PBLS. It has reported private securities offerings to the US SEC, most recently $178 million sold in a notice filed in 2022.
Parabilis Medicines at a glance
What does Parabilis Medicines do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $178 million sold (2022).
Frequently asked questions about Parabilis Medicines
Where is Parabilis Medicines headquartered?
Parabilis Medicines, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Parabilis Medicines do?
Parabilis Medicines, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Parabilis Medicines a public company?
Yes. Parabilis Medicines, Inc. trades on Nasdaq under the ticker PBLS.
When was Parabilis Medicines founded?
The earliest incorporation on record for Parabilis Medicines, Inc. is in 2015, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.